Rigor and Reproducibility: A Systematic Review of Salivary Cortisol Sampling and Reporting Parameters Used in Cancer Survivorship Research

Abstract

Salivary cortisol is a commonly used biomarker in cancer survivorship research; however, variations in sampling protocols and parameter reporting limit comparisons across studies. Standardized practices to provide rigor and reproducibility of diurnal salivary cortisol sampling and reporting are not well established. Previous systematic reviews examining relationships between diurnal salivary cortisol and clinical outcomes have resulted in mixed findings. It remains unclear which sampling protocols and reporting parameters offer the greatest utility for clinical research. This review examines diurnal salivary cortisol sampling protocols and reporting parameters to evaluate whether a standardized approach is recommended. A comprehensive search of intervention studies among adult cancer survivors including diurnal salivary cortisol resulted in 30 articles for review. Sampling protocols ranged from 1 to 4 days with the majority of studies sampling cortisol for 2 days. Sampling instances ranged from 2 to 7 times per day, with the majority collecting at 4 time points per day. Diurnal cortisol slope and cortisol awakening response (CAR) were the most commonly reported parameters associated with clinical outcomes. Flattened cortisol slopes, blunted CARs, and elevated evening cortisol concentrations were associated with poorer psychosocial and physiological outcomes. Based on our review, we propose that a rigorous, standardized diurnal salivary cortisol sampling protocol should include sampling at key diurnal times across ≥3 consecutive days to report diurnal cortisol parameters (i.e., CAR and slope) and objective measures of participant protocol adherence. Diminishing budgetary resources and efforts to minimize participant burden dictate the importance of standardized cortisol sampling protocols and reporting parameters.

Keywords

best practices cancer cortisol measurement review rigor salivary cortisol

Get full access to this article

View all access options for this article.

References

Adam

E. K.

Kumari

(2009). Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology, 34, 1423–1436. doi:10.1016/j.psyneuen.2009.06.011

Bower

J. E.

Greendale

Crosswell

A. D.

Garet

Sternlieb

Ganz

P. A.

… Cole

S. W.

(2014). Yoga reduces inflammatory signaling in fatigued breast cancer survivors: A randomized controlled trial. Psychoneuroendocrinology, 43, 20–29. doi:10.1016/j.psyneuen.2014.01.019

Campo

R. A.

Light

K. C.

O’Connor

Nakamura

Lipschitz

LaStayo

P. C.

… Kinney

A. Y.

(2015). Blood pressure, salivary cortisol, and inflammatory cytokine outcomes in senior female cancer survivors enrolled in a tai chi chih randomized controlled trial. Journal of Cancer Survivorship, 9, 115–125. doi:10.1007/s11764-014-0395-x

Carlson

L. E.

Campbell

T. S.

Garland

S. N.

Grossman

(2007). Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. Journal of Behavioral Medicine, 30, 45–58. doi:10.1007/s10865-006-9082-3

Cash

Sephton

S. E.

Chagpar

A. B.

Spiegel

Rebholz

W. N.

Zimmaro

L. A.

… Dhabhar

F. S.

(2015). Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery. Brain, Behavior, and Immunity, 48, 102–114. doi:10.1016/j.bbi.2015.02.017

Chan

C. L. W.

R. T. H.

Lee

P. W. H.

Cheng

J. Y. Y.

Leung

P. P. Y.

Foo

… Spiegel

(2006). A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients. Journal of Psychosocial Oncology, 24, 3–26.

Clow

Thorn

Evans

Hucklebridge

(2004). The awakening cortisol response: Methodological issues and significance. Stress: The International Journal on the Biology of Stress, 7, 29–37. doi:10.1080/10253890410001667205

Costanzo

E. S.

Stawski

R. S.

Ryff

C. D.

Coe

C. L.

Almeida

D. M.

(2012). Cancer survivors’ responses to daily stressors: Implications for quality of life. Health Psychology, 31, 360–370. doi:10.1037/a0027018

Couture-Lalande

M. È.

Lebel

Bielajew

(2014). Analysis of the cortisol diurnal rhythmicity and cortisol reactivity in long-term breast cancer survivors. Breast Cancer Management, 3, 465–476. doi:10.2217/bmt.14.37

10.

Cuevas

B. T.

Hughes

D. C.

Parma

D. L.

Treviño-Whitaker

R. A.

Ghosh

Ramirez

A. G.

(2014). Motivation, exercise, and stress in breast cancer survivors. Supportive Care in Cancer, 22, 911–917.

11.

Dearholt

Dang

(2012). Johns Hopkins nursing evidence-based practice: Model and guidelines (2nd ed.). Indianapolis, IN: Sigma Theta Tau International Honor Society of Nursing.

12.

Dedert

Lush

Chagpar

Dhabhar

F. S.

Segerstrom

S. C.

Spiegel

… Sephton

S. E.

(2012). Stress, coping, and circadian disruption among women awaiting breast cancer surgery. Annals of Behavioral Medicine, 44, 10–20. doi:10.1007/s12160-012-9352-y

13.

Fekedulegn

D. B.

Andrew

M. E.

Burchfiel

C. M.

Violanti

J. M.

Hartley

T. A.

Charles

L. E.

Miller

D. B.

(2007). Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosomatic Medicine, 69, 651–659.

14.

Giese-Davis

Wilhelm

F. H.

Conrad

Abercrombie

H. C.

Sephton

Yutsis

… Spiegel

(2006). Depression and stress reactivity in metastatic breast cancer. Psychosomatic Medicine, 68, 675–683. doi:10.1097/01.psy.0000238216.88515.e5

15.

Granger

D. A.

Johnson

S. B.

Szanton

S. L.

Out

Schumann

L. L.

(2012). Incorporating salivary biomarkers into nursing research: An overview and review of best practices. Biological Research for Nursing, 14, 347–356. doi:10.1177/1099800412443892

16.

R. T.

Fong

T. C.

Chan

C. K.

Chan

C. L.

(2013). The associations between diurnal cortisol patterns, self-perceived social support, and sleep behavior in Chinese breast cancer patients. Psychoneuroendocrinology, 38, 2337–2342. doi:10.1016/j.psyneuen.2013.05.004

17.

Hoyt

M. A.

Marin-Chollom

A. M.

Bower

J. E.

Thomas

K. S.

Irwin

M. R.

Stanton

A. L.

(2014). Approach and avoidance coping: Diurnal cortisol rhythm in prostate cancer survivors. Psychoneuroendocrinology, 49, 182–186. doi:10.1016/j.psyneuen.2014.07.007

18.

Hsiao

F. H.

Chang

K. J.

Kuo

W. H.

Huang

C. S.

Liu

Y. F.

Lai

Y. M.

… Chan

C. L.

(2013). A longitudinal study of cortisol responses, sleep problems, and psychological well-being as the predictors of changes in depressive symptoms among breast cancer survivors. Psychoneuroendocrinology, 38, 356–366. doi:10.1016/j.psyneuen.2012.06.010

19.

Hsiao

F. H.

Jow

G. M.

Kuo

W. H.

Chang

K. J.

Liu

Y. F.

R. T.

… Chen

Y. T.

(2012). The effects of psychotherapy on psychological well-being and diurnal cortisol patterns in breast cancer survivors. Psychotherapy and Psychosomatics, 81, 173–182. doi:10.1159/000329178

20.

Hsiao

F. H.

Kuo

W. H.

Jow

G. M.

Chang

K. J.

Yang

P. S.

Lam

H. B.

… Lai

Y. M.

(2015). Habitual sleep-wake behaviors and lifestyle as predictors of diurnal cortisol patterns in young breast cancer survivors: A longitudinal study. Psychoneuroendocrinology, 53, 60–68.

21.

Hsiao

C. P.

Moore

I. M.

Insel

K. C.

Merkle

C. J.

(2011). High perceived stress is linked to afternoon cortisol levels and greater symptom distress in patients with localized prostate cancer. Cancer Nursing, 34, 470–478. doi:10.1097/NCC.0b013e31820a5943

22.

Hulett

J. M.

Armer

J. M.

Leary

Stewart

B. R.

McDaniel

Smith

… Millspaugh

(2018). Religiousness, spirituality, and salivary cortisol in breast cancer survivorship: A pilot study. Cancer Nursing, 41, 166–175. doi:10.1097/NCC.0000000000000471

23.

Jacobs

Nicolson

N. A.

Derom

Delespaul

van Os

Myin-Germeys

(2005). Electronic monitoring of salivary cortisol sampling compliance in daily life. Life Science, 76, 2431–2443. doi:10.1016/j.lfs.2004.10.045

24.

Khoury

J. E.

Gonzalez

Levitan

R. D.

Pruessner

J. C.

Chopra

Basile

V. S.

… Atkinson

(2015). Summary of cortisol reactivity indicators: Interrelations and meaning. Neurobiology of Stress, 2, 34–43. doi:10.1016/j.ynstr.2015.04.002

25.

Kim

K. S.

Kim

Y. C.

I. J.

Kim

S. S.

Choi

J. Y.

Ahn

R. S.

(2012). Association of worse prognosis with an aberrant diurnal cortisol rhythm in patients with advanced lung cancer. Chronobiology International, 29, 1109–1120. doi:10.3109/07420528.2012.706767

26.

Kosaka

Sumita

Y. I.

Otomaru

Taniguchi

(2014). Differences of salivary cortisol levels between long-term and short-term wearers of dento-maxillary prosthesis due to head and neck cancer resection. Journal of Prosthodontic Research, 58, 41–47. doi:10.1016/j.jpor.2013.10.001

27.

Loizzo

J. J.

Peterson

J. C.

Charlson

M. E.

Wolf

E. J.

Altemus

Briggs

W. M.

… Caputo

T. A.

(2010). The effect of a contemplative self-healing program on quality of life in women with breast and gynecologic cancers. Alternative Therapies in Health and Medicine, 16, 30–37.

28.

Lutgendorf

S. K.

Weinrib

A. Z.

Penedo

Russell

DeGeest

Costanzo

E. S.

… Lubaroff

D. M.

(2008). Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. Journal of Clinical Oncology, 26, 4820–4827. doi:10.1200/jco.2007.14.1978

29.

Matchim

Armer

J. M.

Stewart

B. R.

(2011). Effects of mindfulness-based stress reduction (MBSR) on health among breast cancer survivors. Western Journal of Nursing Research, 33, 996–1016. doi:10.1177/0193945910385363

30.

Matousek

R. H.

Pruessner

J. C.

Dobkin

P. L.

(2011). Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer. Complementary Therapies in Clinical Practice, 17, 65–70. doi:10.1016/j.ctcp.2010.10.005

31.

McEwen

B. S.

(1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171–179. doi:10.1056/NEJM199801153380307

32.

Mundy-Bosse

B. L.

Thornton

L. M.

Yang

H. C.

Andersen

B. L.

Carson

W. E.

(2011). Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cellular Immunology, 270, 80–87. doi:10.1016/j.cellimm.2011.04.003

33.

National Institutes of Health. (2016). Rigor and reproducibility. Bethesda, MD: Author. Retrieved from https://www.nih.gov/research-training/rigor-reproducibility

34.

Palesh

Zeitzer

J. M.

Conrad

Giese-Davis

Mustian

K. M.

Popek

… Spiegel

(2008). Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. Journal of Clinical Sleep Medicine, 4, 441–449.

35.

Pruessner

J. C.

Wolf

O. T.

Hellhammer

D. H.

Buske-Kirschbaum

von Auer

Jobst

… Kirschbaum

(1997). Free cortisol levels after awakening: A reliable biological marker for the assessment of adrenocortical activity. Life Science, 61, 2539–2549. doi:10.1016/S0024-3205(97)01008-4

36.

Ryan

Booth

Spathis

Mollart

Clow

(2016). Use of salivary diurnal cortisol as an outcome measure in randomised controlled trials: A systematic review. Annals of Behavioral Medicine, 50, 210–236. doi:10.1007/s12160-015-9753-9

37.

Scherling

Collins

Mackenzie

Bielajew

Smith

(2011). Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: An FMRI study. Frontiers in Human Neuroscience, 5, 122. doi:10.3389/fnhum.2011.00122

38.

Schmidt

M. E.

Semik

Habermann

Wiskemann

Ulrich

C. M.

Steindorf

(2016). Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients. Brain, Behavior, and Immunity, 52, 98–105.

39.

Schrepf

Clevenger

Christensen

DeGeest

Bender

Ahmed

… Lutgendorf

S. K.

(2013). Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability. Brain, Behavior, and Immunity, 30, S126–S134. doi:10.1016/j.bbi.2012.07.022

40.

Schrepf

Thaker

P. H.

Goodheart

M. J.

Bender

Slavich

G. M.

Dahmoush

… Lutgendorf

S. K.

(2015). Diurnal cortisol and survival in epithelial ovarian cancer. Psychoneuroendocrinology, 53, 256–267.

41.

Segerstrom

S. C.

Boggero

I. A.

Smith

G. T.

Sephton

S. E.

(2014). Variability and reliability of diurnal cortisol in younger and older adults: Implications for design decisions. Psychoneuroendocrinology, 49, 299–309. doi:10.1016/j.psyneuen.2014.07.022

42.

Sephton

S. E.

Lush

Dedert

E. A.

Floyd

A. R.

Rebholz

W. N.

Dhabhar

F. S.

… Salmon

(2013). Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain, Behavior, and Immunity, 30, S163–S170. doi:10.1016/j.bbi.2012.07.019

43.

Stalder

Kirschbaum

Kudielka

B. M.

Adam

E. K.

Pruessner

J. C.

Wust

… Clow

(2016). Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology, 63, 414–432. doi:10.1016/j.psyneuen.2015.10.010

44.

Subnis

U. B.

Starkweather

A. R.

McCain

N. L.

Brown

R. F.

(2013). Psychosocial therapies for patients with cancer: A current review of interventions using psychoneuroimmunology-based outcome measures. Integrative Cancer Therapies, 13, 85–104.

45.

Tell

Mathews

H. L.

Janusek

L. W.

(2014). Day-to-day dynamics of associations between sleep, napping, fatigue, and the cortisol diurnal rhythm in women diagnosed as having breast cancer. Psychosomatic Medicine, 76, 519–528. doi:10.1097/psy.0000000000000097

46.

Weinrib

A. Z.

Sephton

S. E.

DeGeest

Penedo

Bender

Zimmerman

… Lutgendorf

S. K.

(2010). Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer, 116, 4410–4419.

47.

Witek-Janusek

Gabram

Mathews

H. L.

(2007). Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology, 32, 22–35. doi:10.1016/j.psyneuen.2006.09.011

48.

Zeitzer

J. M.

Nouriani

Neri

Spiegel

(2014). Correspondence of plasma and salivary cortisol patterns in women with breast cancer. Neuroendocrinology, 100, 153–161. doi:10.1159/000367925